Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

HealthSource vs NovoCare Pharmacy

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

HealthSource logo

HealthSource

6.5
★★★☆☆3.3

Best for: compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo

Visit HealthSource
VS
NovoCare Pharmacy logo

NovoCare Pharmacy

8.7
★★★★4.4

Best for: branded Wegovy at the lowest manufacturer-direct self-pay price

Visit NovoCare Pharmacy

HealthSource and NovoCare Pharmacy are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, NovoCare Pharmacy starts lower at $149/mo versus $199/mo, and NovoCare Pharmacy edges ahead overall (8.7 vs 6.5 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

HealthSource

All dosesCompounded
$199/mo
semaglutide

Verbatim from product page: 'From: $199.00 every 4 weeks.' Medication is compounded semaglutide+B12 in vial form with syringes and alcohol pads. Multiple dose tiers available (Full Dose, Starter 4-week, Starter 6-week, 8-week); $199 is entry-tier price.

All dosesCompounded
$299/mo
tirzepatide

Verbatim from product page: 'From: $299.00 every 4 weeks.' Injectable tirzepatide dispensed through 503A partner pharmacy. Multiple dose tiers available; $299 is entry-tier price.

Oral sublingualCompounded
$399/mo
tirzepatide

Verbatim from product page: 'From: $399.00 every 4 weeks.' Oral sublingual tirzepatide tablet taken once daily before bed; ships in 5–10 business days. $399 is entry-tier price.

NovoCare Pharmacy

Wegovy pill (oral semaglutide tablets, 1.5 mg / 4 mg)oral
$149/mo
semaglutide

$149/mo for 1.5 mg and 4 mg new self-pay; 4 mg offer ends 8/31/2026, then $199/mo for 4 mg

Wegovy pen 0.25-2.4 mg (standard self-pay)Brand-name
$349$199/mo
Save 43% right now
semaglutide

$199/mo intro = first 2 monthly fills (0.25/0.5 mg) for patients new to the offer/pharmacy, through 6/30/2026; then $349/mo standard

Wegovy HD pen 7.2 mg (high-dose self-pay)Brand-name
$399/mo
semaglutide
Wegovy with commercial insurance (copay)Brand-name
$25/mo
semaglutide

with commercial insurance, as little as $25/mo; subject to max savings of $100/month

What’s included

HealthSource

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

NovoCare Pharmacy

Inclusions not disclosed.

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

HealthSource

6.5/10

Overall

NovoCare Pharmacy

8.7/10

Value25%

6.0A
vs
B
8.5

Effectiveness25%

6.5A
vs
B
9.0

User Experience15%

6.0A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
9.5

Accessibility10%

8.0A
vs
B
9.0

Support10%

7.5A
vs
B
8.0

Features & Coverage

FeatureHealthSourceNovoCare Pharmacy
Starting Price$199/mo$149/mo
Features8 features5 features
States Available5050
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About HealthSource

HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy. Starting from $199/month for semaglutide, each subscription covers the cost of medication, supplies, a telehealth visit with a board-certified physician, and unlimited provider messaging through a HIPAA-compliant platform. Services are available in all 50 US states with direct-to-door delivery in 3–5 business days.

Read our full HealthSource review →

About NovoCare Pharmacy

Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide). Manufacturer-owned channel: Wegovy 0.25 mg / 0.5 mg starter doses at $199/month through 6/30/2026; full-dose Wegovy at $349/month standard self-pay; Wegovy HD at $399/month. Ships nationwide. Distinct from telehealth platforms that route Wegovy through NovoCare — this is the manufacturer pharmacy itself.

Read our full NovoCare Pharmacy review →

Pros & Cons

HealthSource

What we like

  • Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
  • 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
  • Every program covers the cost of medication, supplies, and telehealth visits — no separate pharmacy fee
  • Subscription auto-refund if monthly reassessment is not completed
  • Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping

Watch-outs

  • No physician names or clinical leadership disclosed on public pages
  • No LegitScript certification found
  • 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy
  • Labs not mentioned on any product page — baseline bloodwork protocol unknown
  • WooCommerce e-commerce storefront may feel more transactional than clinical

NovoCare Pharmacy

What we like

  • First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
  • $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
  • $349/mo standard self-pay is well below the ~$1,300/mo retail list price
  • Ships to all 50 states with no telehealth-platform middleman fees
  • Cold-chain logistics handled directly by Novo Nordisk
  • Insurance-billing path available via the NovoCare savings program
  • NEW $149/mo Wegovy pill (oral semaglutide tablets, 1.5/4 mg) self-pay tier — 4 mg rises to $199/mo after 8/31/2026

Watch-outs

  • Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
  • Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
  • No clinical support included — your own prescriber handles titration and side effects
  • Manufacturer-set pricing can change at any time
  • $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)

Our Verdict

Winner: NovoCare Pharmacy

NovoCare Pharmacy edges out HealthSource with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. HealthSource remains a solid alternative, especially if you're looking for compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.

Choose HealthSource if…

You want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo and a starting price around $199/mo.

Choose NovoCare Pharmacy if…

You want branded Wegovy at the lowest manufacturer-direct self-pay price and a starting price around $149/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online, ranked by our editorial score.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.6

Enhance MD

Lab-monitored compounded GLP-1 with mandatory video visit

8.5

Embody

Lowest first-month entry pricing on compounded GLP-1s

8.5

TrimRx

Best overall value

HealthSource vs NovoCare Pharmacy: FAQ

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Related comparisons

Continue exploring HealthSource and NovoCare Pharmacy head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.